tiprankstipranks
Trending News
More News >
Spyre Therapeutics (SYRE)
NASDAQ:SYRE
US Market

Spyre Therapeutics (SYRE) Ownership - Who Owns Spyre Therapeutics?

Compare
445 Followers

Spyre Therapeutics (SYRE) Ownership Overview

9.67%20.88%0.06%10.25%59.15%
0.06% Other Institutional Investors
10.25% ETFs
59.15% Public Companies and
Individual Investors
The ownership structure of Spyre Therapeutics (SYRE) stock is a mix of institutional, retail, and individual investors. Approximately 31.18% of the company’s stock is owned by Institutional Investors, 9.67% is owned by Insiders, and 59.15% is owned by Public Companies and Individual Investors.
The ownership structure of Spyre Therapeutics (SYRE) stock is a mix of institutional, retail, and individual investors. Approximately 20.94% of the company’s stock is owned by Institutional Investors, 9.67% is owned by Insiders, and 10.25% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Sep 05, 2024
xxxxxxxxxxxxx
$522018

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Dec 31, 2024
xxxxxxxxxxxxx
$5820000
Dec 31, 2024
xxxxxxxxxxxxx
$8210390
Dec 31, 2024
xxxxxxxxxxxxx
$10457399
Dec 31, 2024
xxxxxxxxxxxxx
$10476000

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
4,830,177Insider8.02%61,391,550
4,018,101Institution6.67%51,070,064
2,803,655Institution4.65%35,634,455
2,717,708Institution4.51%34,542,069
2,574,723Institution4.27%32,724,729
2,416,404Institution4.01%30,712,495
2,153,592Institution3.57%27,372,154
1,926,853Institution3.20%24,490,302
1,438,969Institution2.39%18,289,296
1,021,368Institution1.70%12,981,587

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,416,404Institution4.01%30,712,495
2,153,592Institution3.57%27,372,154
1,438,969Institution2.39%18,289,296
1,021,368Institution1.70%12,981,587
929,395Institution1.54%11,812,610
623,284Institution1.03%7,921,940
474,232Institution0.79%6,027,489
384,130Institution0.64%4,882,292
378,573Institution0.63%4,811,663
339,902Institution0.56%4,320,154

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,660,257Institution2.76%32,707,063
1,010,927Institution1.68%12,848,882
878,644Institution1.46%11,439,945
757,755Institution1.26%14,927,774
339,899Institution0.56%4,320,116
329,438Institution0.55%4,187,157
235,190Institution0.39%3,062,174
159,247Institution0.26%3,137,166
111,207Institution0.18%2,190,778
59,002Institution0.10%749,915

FAQ

Who Owns Spyre Therapeutics (SYRE)?
According to the latest TipRanks data, approximately 0.06% of the company's stock is held by institutional investors, 9.67% is held by insiders, and 59.15% is held by retail investors.
    What percentage of Spyre Therapeutics (SYRE) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.06% of Spyre Therapeutics (SYRE) stock is held by institutional investors.
      What percentage of Spyre Therapeutics (SYRE) stock is held by retail investors?
      According to the latest TipRanks data, approximately 59.15% of Spyre Therapeutics (SYRE) stock is held by retail investors.
        Who owns the most shares of Spyre Therapeutics (SYRE)?
        Fairmount Funds Management LLC owns the most shares of Spyre Therapeutics (SYRE).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis